XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK OPTIONS
 6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK OPTIONS

NOTE 6 – STOCK OPTIONS

 

The following table presents the Company’s stock option activity for employees and directors of the Company for the six months ended June 30, 2024:

 

  

 

Number of Options

   Weighted Average Exercise Price 
Outstanding at December 31, 2023   27,518    23.69 
Granted   -    - 
Exercised   -    - 
Forfeited or expired   -    - 
Outstanding at June 30, 2024   27,518    23.69 
Number of options exercisable at June 30, 2024   27,518    23.69 

 

The aggregate intrinsic value of the awards outstanding as of June 30, 2024 was $0. These amounts represent the total intrinsic value, based on the Company’s stock price of $0.48 as of June 30, 2024, less the weighted exercise price. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.

 

Costs incurred in respect of stock-options compensation for employees and directors, for the six months ended June 30, 2024 and 2023 were $0 and $14,247, respectively and $0 and $5,787, for the three months ended June 30, 2024 and 2023, respectively.